Device Spinal Cord Neurostimulation

Intellis Adaptivestim

Payments companies reported to CMS as associated with Intellis Adaptivestim. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$9.2Massociated payments (2023-2025)
21,472clinicians with associated payments
1company reporting

By year

2023 $3.0M
2024 $4.0M
2025 $2.2M

Payments reported as associated with Intellis Adaptivestim, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Anesthesiology) $2.5M
Interventional Pain Medicine $1.4M
Anesthesiology $788K
Pain Medicine (Physical Medicine & Rehabilitation) $590K
Neurological Surgery $480K
Physical Medicine & Rehabilitation $389K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Intellis Adaptivestim

These are the largest totals companies reported as associated with Intellis Adaptivestim. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Melissa Murphy Grapevine, TX Pain Medicine (Anesthesiology) $347,334.97
Krishnan Chakravarthy Temecula, CA Pain Medicine (Anesthesiology) $304,927.47
Yair Safriel Clearwater, FL Diagnostic Radiology $240,334.74
Christopher Beuer Saint Louis, MO Anesthesiology $185,664.04
Phillip Smith Greenville, SC Pain Medicine (Anesthesiology) $144,966.90
Matthias Wiederholz Lawrenceville, NJ Pain Medicine (Physical Medicine & Rehabilitation) $142,309.99
Alexander Taghva Mission Viejo, CA Neurological Surgery $141,842.73
Ricardo Vallejo Bloomington, IL Pain Medicine (Anesthesiology) $128,709.83
John Hatheway Coeur D Alene, ID Interventional Pain Medicine $119,183.72
Tammy Dann Dayton, OH Pain Medicine (Anesthesiology) $97,056.97

Prescribed Intellis Adaptivestim?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.